Long-term intravesical oxybutynin for neurogenic bladder in children has good urodynamic and renal outcome
- 28 January 2025
- journal article
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (3) , 661-669
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Population Pharmacokinetic Model of (R)‐ and (S‐) Oxybutynin and Its Active Metabolites After Oral and Intravesical Administration to Healthy VolunteersThe Journal of Clinical Pharmacology, 2020
- International Children's Continence Society standardization report on urodynamic studies of the lower urinary tract in childrenNeurourology and Urodynamics, 2015
- Efficacy, safety, and tolerability of intravesically administered 0.1% oxybutynin hydrochloride solution in adult patients with neurogenic bladder: A randomized, prospective, controlled multi‐center trialNeurourology and Urodynamics, 2015
- Diagnostic accuracy of Tc-99m DMSA scintigraphy and renal ultrasonography for detecting renal scarring and relative function in patients with spinal dysraphismNeurourology and Urodynamics, 2014
- Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: With special reference to age-dependent parametersNeurourology and Urodynamics, 2014
- Methods of assessing renal functionPediatric Nephrology, 2013
- The neurogenic bladder: medical treatmentPediatric Nephrology, 2008
- Risk factors for renal scarring in children and adolescents with lower urinary tract dysfunctionPediatric Nephrology, 2007
- Oxybutynin and the overactive bladderWorld Journal of Urology, 2001
- International system of radiographic grading of vesicoureteric refluxPediatric Radiology, 1985